Clinical Trials

75 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02584478 2023-11-08

AL3818

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06110663 2023-11-01

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

314 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03952403 2023-08-08

A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

643 enrolled

Tumor-Agnostic

Carcinoma

NCT04033354 2023-08-08

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

537 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04297995 2023-08-08

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

131 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05783921 2023-07-28

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1/2 Unknown

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT05794477 2023-06-02

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

132 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

65 enrolled

Breast

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT05741021 2023-02-24

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT04346914 2022-05-11

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

20 enrolled

Extensive Stage Small Cell Lung Cancer

NCT05354700 2022-05-04

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

20 enrolled

Small Cell Lung Carcinoma

NCT05346952 2022-04-26

A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).

390 enrolled

Advanced Non-squamous Non-small Cell Lung Cancer

NCT03711305 2022-04-18

Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

462 enrolled

Small Cell Lung Carcinoma

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

561 enrolled

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

72 enrolled

Other solid neoplasm

Solid Tumor

NCT04691063 2021-02-26

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

486 enrolled

Small Cell Lung Carcinoma

NCT04750083 2021-02-11

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Phase 2/3 Unknown

700 enrolled

Nonsquamous Non-small Cell Lung Cancer

NCT04740021 2021-02-05

Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

46 enrolled

Small Cell Lung Carcinoma

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT03912389 2020-09-17

DOMAJOR

292 enrolled

Non-Squamous Non-Small Cell Neoplasm of Lung

NCT04416035 2020-08-31

NSCLC

608 enrolled

Advanced Non-squamous Non-small-cell Lung Cancer

NCT04439890 2020-06-19

A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

369 enrolled

Advanced Non-squamous Cell Non-small Cell Lung Cancer

NCT04203485 2020-05-08

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

762 enrolled

PD-L1 Positive Non-small Cell Lung Cancer

NCT04234607 2020-01-22

A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)

738 enrolled

Extensive Small Cell Lung Cancer

NCT03855384 2019-10-30

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

334 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04054531 2019-09-10

Study of KN046 With Chemotherapy in First Line Advanced NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04073537 2019-08-29

Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer

386 enrolled

Squamous Non-small Cell Lung Cancer

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

49 enrolled

Uterine Cervical Neoplasms

NCT03792074 2019-01-03

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

560 enrolled

Non-squamous Cell Non-small Cell Lung Cancer

NCT03503604 2018-04-20

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

18 enrolled

Other solid neoplasm

Solid Tumors

NCT03413358 2018-01-29

Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid

Phase NA Unknown

240 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03262948 2017-11-13

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

388 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03195569 2017-06-22

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Unknown

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02906150 2016-09-19

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02879097 2016-08-25

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01555710 2013-05-21

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

548 enrolled

Small Cell Lung Carcinoma

NCT00635557 2011-03-25

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Phase 1/2 Unknown

30 enrolled

CNS

Glioblastoma, Recurrence

NCT00669747 2008-10-02

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)